The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 23, 2018

Filed:

Apr. 29, 2015
Applicants:

Bluebird Bio, Inc., Cambridge, MA (US);

Massachusetts Institute of Technology, Cambridge, MA (US);

Inventors:

Philippe Louis Leboulch, Bangkok, TH;

Robert Pawliuk, Medford, MA (US);

Karen Westerman, Reading, MA (US);

Assignees:

bluebird bio, Inc., Cambridge, MA (US);

Massachusetts Institute of Technology, Cambridge, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 63/00 (2006.01); C12N 15/00 (2006.01); C07H 21/04 (2006.01); A61K 48/00 (2006.01); A01K 67/027 (2006.01); C07K 14/805 (2006.01); C12N 15/85 (2006.01); C12N 15/86 (2006.01); A61K 38/42 (2006.01); C12N 15/867 (2006.01); C12N 15/63 (2006.01);
U.S. Cl.
CPC ...
A61K 48/0058 (2013.01); A01K 67/0278 (2013.01); A61K 38/42 (2013.01); C07K 14/805 (2013.01); C12N 15/8509 (2013.01); C12N 15/86 (2013.01); A01K 2207/15 (2013.01); A01K 2217/00 (2013.01); A01K 2227/105 (2013.01); A01K 2267/03 (2013.01); A61K 48/00 (2013.01); C07H 21/04 (2013.01); C12N 15/63 (2013.01); C12N 15/867 (2013.01); C12N 2510/00 (2013.01); C12N 2740/15043 (2013.01); C12N 2740/16011 (2013.01); C12N 2740/16043 (2013.01); C12N 2830/008 (2013.01); C12N 2830/40 (2013.01);
Abstract

The invention provides improved compositions and methods for achieving gene therapy in hematopoietic cells and hematopoietic precursor cells, including erythrocytes, erythroid progenitors, and embryonic stem cells. The invention further provides improved gene therapy methods for treating hematopoietic-related disorders. Retroviral gene therapy vectors that are optimized for erythroid specific expression and treatment of hemoglobinopathic conditions are disclosed.


Find Patent Forward Citations

Loading…